Latest Luminex Cor (LMNX) Headlines
Global Flow Cytometry (Products, Application, Technology, and Users) Market Report 2012-2020
M2 - Thu Mar 06, 11:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/hrg48g/flow_cytometry) has announced the addition of the "Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020" report to their offering. The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9% Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches. KEY MARKET SEGMENTS BY PRODUCT - FC instruments - Reagents - Consumables - Software - Services - Accessories BY TECHNOLOGY - Cell based Technologies - Bead-based Technologies BY APPLICATION - Clinical - Apoptosis - Cell Cycle Analysis - Cell sorting - Cell Viability - Research Fields - Organ transplantation - Cancer - Immunodeficiency Disease - Hematology Haematological Malignancies BY END USERS - Commercial Organizations - Hospitals - Academic Institutes - Medical Schools - Clinical Testing Labs - Others KEY AUDIENCES: - Clinical institutes - Research institutes - Pharma and biotech companies - Academic institutes Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Flow Cytometry Market Overview Chapter 4 Flow Cytometry Market By Product Chapter 5 Flow Cytometry Market By Technology Chapter 6 Flow Cytometry Market By Application Chapter 7 Flow Cytometry Market By End User Chapter 8 Flow Cytometry Market By Geography Chapter 9 Company Profiles - Advanced Analytical Technologies Inc (AATI) - Amnis Corporation - Beckman Coulter - Becton - Dickinson & Co. - Ebioscience Inc. - Inc. - Life Technologies Corporation - Luminex Corporation - Merck Millipore - Morphosys AG - Partec GmbH For more information visit http://www.researchandmarkets.com/research/hr..._cytometry
NextGxDx Secures Series B Financing Round, Expands Board of Directors
PR Newswire - Wed Mar 05, 7:30AM CST
NextGxDx Inc., which provides an online genetic testing marketplace for healthcare professionals and hospitals, today announced the successful closing of the company's Series B round of financing, which was led by Voyent Partners and joined by the Nashville Capital Network. With the new investment, the company has expanded its board of directors to include new members Patrick J. Balthrop Sr., President and CEO of Luminex Corporation; Phil Hertik, former founder, chairman and CEO of Windsor Health Group; Jim Kever, principal at Voyent Partners; George Lazenby, former CEO of Emdeon; and G. Walter Loewenbaum II, chairman of Luminex Corp. and 3D Systems Corp.
12.6% Return Seen to Date on SmarTrend Luminex Call (LMNX)
Comtex SmarTrend(R) - Mon Mar 03, 11:05AM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 7 months, Luminex has returned 12.60% as of today's recent price of $18.35.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
Luminex Down 10.5% Since SmarTrend Downtrend Call (LMNX)
Comtex SmarTrend(R) - Fri Feb 21, 5:25PM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 7 months, Luminex has returned 10.45% as of today's recent price of $18.80.
High Throughput Screening - Forecast to 2018 Research Report
M2 - Tue Feb 11, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxsthj/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering. 'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018' In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 2013 to 2018. This technology offers the direct detection ability, which was not possible with cell-based assays. Moreover, this technology helps in the reduction of drug failure rate due to toxicity and is applicable for a majority of drug classes. In the HTS applications market, the target identification segment accounted for the largest share in 2013. The large share of this segment can be attributed to factors such as the availability of large compound libraries, presence of well-equipped HTS laboratories, and technological advancements. Large pharmaceutical and biotechnology companies are investing heavily in automation of HTS laboratories and are also entering into strategic partnerships and collaborations with research institutes, thereby leading to efficient utilization of HTS in varied application fields. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview High Throughput Screening Market, By Technology High Throughput Screening Market, By Product Global High Throughput Screening Market, By Application Global High Throughput Screening Market, By End Users Geographic Analysis Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Agilent Technologies, Inc. - Aurora Biomed - Axxam Spa - Beckman Coulter, Inc. (A Subsidiary Of Danaher) - Bio-Rad Laboratories - Biofocus Dpi Ltd. - Intellicyt Corporation - Luminex Corporation - Perkinelmer, Inc. - Sigma Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/mx...throughput About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 9:34AM CST
The decline in earnings can be attributable to lower revenues and higher costs during the quarter.
Luminex Corporation Reports Fourth Quarter And Full Year 2013 Results
PR Newswire - Mon Feb 03, 3:05PM CST
Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2013. Financial and operating highlights include the following:
Microspheres Market by Type, Application & Raw Material - Global Trends & Forecasts to 2018
M2 - Thu Jan 30, 2:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/ph4dlg/microspheres) has announced the addition of the "Microspheres Market by Type, Application & Raw Material - Global Trends & Forecasts to 2018" report to their offering. Rising demand for efficiency and better materials with superior structural properties will drive the global microspheres market to $5.2 billion by 2018. The U.S. leads the world in terms of usage of advanced materials to increase the efficiency and reliability of operations which makes it the biggest market for microspheres. The market here is expected to experience the highest revenue growth during the next five years. The factors driving growth in the global microspheres market are: high demand from current & emerging applications, superior structural properties, recyclable & reusable, development & modernization of infrastructure, and increased demand for efficiency. The factors hindering the growth of this market are the fluctuating cost of raw materials, lack of quality control across developing countries, and huge investment in R&D. The market is growing slowly in Europe & Eurasia but it will continue to grow at significant rate in the Asia-Pacific region. Asia-Pacific is driven by countries such as China, the fastest growing country in global microspheres market. The microspheres market is still in infancy stage in Latin America. But this region is experiencing high growth on account of increased infrastructure spending. On the whole, it is evident that North America and Asia-Pacific are the most lucrative microspheres market. Most players in this industry are very small and manufacture highly customized products focusing on particular end user industry. U.S-based 3M is the largest player in terms of volume sales. Every company, big or small, wants to penetrate deeper into the existing market and at the same time expand into new and emerging markets to increase their sales margin; thereby increasing overall revenue. The companies involved in microspheres business adopted this strategy by expanding into emerging markets such as Asia-Pacific and South America. Most of the major companies manufacturing microspheres are headquartered in the U.S. and Europe. Medical technology will emerge as the most dominant application of the microspheres globally. Within raw material types, glass microspheres offer significant advantages over others and have wide applications in almost all industries such as cosmetics & personal care, paints & coatings, oil & gas and aerospace. Hence these are the market leaders in terms of size. Hollow microspheres being the most used microspheres in the market, captured most of the market. Scope of the report On the basis of geography: - North America - Europe & Eurasia - Asia-Pacific - Middle East & Africa - Latin America On the basis of applications: - Construction Composites - Medical Technology - Life Sciences & Biotechnology - Paints & Coatings - Cosmetics & Personal Care - Oil & Gas - Automotive - Aerospace - Other applications On the basis of types: - Hollow - Solid On the basis of raw materials: - Glass - Ceramic - Fly Ash - Polymer - Metallic - Others Key Topics Covered 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Manufacturing Process 6 Microspheres Market, By Types 7 Microspheres Market, By Applications 8 Microspheres Market, By Raw Materials 9 Microspheres Market, By Geography 10 Competitive Landscape 11 Company Profiles Companies Mentioned - 3M - Akzo Nobel Expancel - Cospheric - Dennert Poraver - Eko Export Sa - Henkel Ag & Co Kgaa - Induchem Holding - Luminex Corporation - MO Sci Corporation - Matsumoto Yushi-Seiyaku - Merit Medical Systems - Momentive Performance Materials - Osthoff Omega Group - Phosphorex Inc - Polysciences Incorporation - Potters Industries - Sigmund Lindner - Sinosteel Maanshan Institute Of Minning Research Company - Spherotech - Sunjin Chemical Co - Trelleborg Offshore & Construction For more information visit http://www.researchandmarkets.com/research/ph...crospheres About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Luminex Corporation To Present At 2014 Leerink Global Healthcare Conference
PR Newswire - Wed Jan 29, 3:05PM CST
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 2014 Leerink Global Healthcare Conference to be held February 12 -13, 2014, in New York, NY.
Downtrend Call Working As Luminex Stock Falls 12.9% (LMNX)
Comtex SmarTrend(R) - Tue Jan 28, 9:32AM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 6 months, Luminex has returned 12.93% as of today's recent price of $18.28.
2013 Report on the International Flow Cytometry Market - Forecasts to 2016
M2 - Mon Jan 27, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddp8kh/global_flow) has announced the addition of the "2013 Report on the International Flow Cytometry Market - Forecasts to 2016" report to their offering. A large number of companies are operating in the Global Flow Cytometry market. In recent years, the Global Flow Cytometry market has been witnessing significant consolidation as a result of many mergers and acquisitions. This trend is expected to continue during the forecast period as vendors attempt to strengthen or retain their market position. The market consolidation has resulted in stronger competitors that are better able to compete as sole-source vendors to end-users. For instance, in March 2011, Becton, Dickinson and Company completed the acquisition of Accuri Cytometers Inc., and in August 2011, EMD Millipore acquired Amnis Corp. One of the key drivers is the increase in technological advancements. The latest technological advancements and sophisticated approaches in various healthcare operations have increased the demand for flow cytometry. The technological innovations employed in the drug discovery and development process require flow cytometry on a large scale. The introduction of compact affordable flow cytometry equipment and user-friendly software has helped in moving flow cytometry from core laboratories to small research facilities. The introduction of multicolor flow cytometers with multiple lasers that are capable of simultaneously detecting up to 18 cell parameters is also having a strong impact on the growth of the market. Further, the report reveals that one of the key challenges is the intense competition among the flow cytometer vendors. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Buying Criteria 8. Market Growth Drivers 9. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 14. Other Reports in this Series Companies Mentioned: - Becton - Dickinson and Company - Danaher Corp. - EMD Millipore Corp. - Cytek Development Inc. - Cytopeia Inc. - Partec GmbH - TTP LabTech Ltd. - eBioscience Inc. - Luminex Corp. - Sony Biotechnology Inc. For more information visit http://www.researchandmarkets.com/research/dd...lobal_flow
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
PR Newswire - Tue Jan 14, 3:05PM CST
Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter of 2013 on Monday, February 3, 2014. A press release announcing the results is scheduled for release after the close of trading.
North America to Lead Flow Cytometry Market Till 2020, States Allied Market Research in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 08, 9:52AM CST
The flow cytometry market is currently on an upward trend, driven by ongoing technological advancements alongside the advantages the flow cytometry technology has, such as easy-to-handle instruments, auto-calibration, and broader accessibility. The key restraints to the market growth include, among others, the lack of awareness amid prospective users, the increasing need for trained personnel, and high size and cost of instruments. Hospitals, commercial organisations, clinical testing laboratories, medical schools and academic institutes are the main end-users of the technology. The entrenched players of the worldwide flow cytometry market include, amid others, Morphosys AG, Partech GmbH, Beckman Coulter, Life technologies, Amnis, eBioscience Inc, Luminex Corporation, and Becton Dickinson & Co.
Downgrade Alert for Luminex (LMNX)
Comtex SmarTrend(R) - Wed Jan 08, 7:03AM CST
Luminex (NASDAQ:LMNX) was downgraded from Neutral to Underweight at JP Morgan today. The stock closed yesterday at $18.48 on volume of 331,000 shares, above average daily volume of 141,000. There is potential upside of 5.5% for shares of Luminex based on a current price of $18.48 and an average consensus analyst price target of $19.50. Luminex shares should first meet resistance at the 50-day moving average (MA) of $18.86 and find additional resistance at the 200-day MA of $19.37.
Luminex Corporation To Present At JP Morgan Healthcare Conference
PR Newswire - Thu Jan 02, 3:05PM CST
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 32nd Annual JP Morgan Healthcare Conference to be held January 13-16, 2014, in San Francisco, CA.
Global Microarray Market Report 2013
M2 - Tue Dec 17, 4:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/6rcmmv/microarray_markets) has announced the addition of the "Global Microarray Market Report 2013" report to their offering. "Global Microarray Market Report 2013", focuses on microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics. Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips. Detailed tables and charts with sales forecasts and marketshare data are also included. Key Topics Covered: 1. Overview 2. The Commercial Opportunity for Microarrays 3. Microarray Overview 4. DNA Microarrays 5. Protein Microarrays 6. Current DNA Microarrays 7. Current Protein Microarrays 8. Technology 9. Lab-on-a-Chip Technologies 10. Applications 10.1 DNA Microarrays in Gene Expression 10.2 DNA Microarrays in SNP Analysis 10.3 DNA Microarrays in Cancer 10.4 Protein Microarrays 10.5 Target/Biomarker Discovery 10.6 Drug Discovery and Development (Gene and Protein Microarrays) 10.7 Clinical Diagnostics (Gene and Protein Microarrays) 10.8 RNA Microarrays 10.9 Oligo Microarrays 10.10 Yeast Microarrays 10.11 Antibody Arrays 10.12 Arrays for Toxicogenomics 10.13 Microbial Applications 10.14 The Market for Microbial Genotyping Products 11. Competitive Landscape 11.1 The Commercial Microarray Market 11.2 Sector Consolidation 11.3 Regulatory Matters 11.4 Legal Matters 11.5 Intellectual Property 11.6 Mergers, Acquisitions and Agreements 12. Company Profiles Companies Mentioned: - AyoxxA - bioM rieux SA - CombiMatrix Corporation - Discerna - Exiqon - Fluidigm Corporation - Gyros AB - Healthcare IT, Inc - Isu Abxis Co, Ltd - Luminex Corporation - Myriad Genetics, Inc - NextGen Sciences PLC - One Lambda - ProteoGenix - QIAGEN - Roche NimbleGen, Inc - SuperBioChips Laboratories - Theranostic Health, Inc - US Biomax - Veredus Laboratories Pte Ltd - Zeptosens For more information visit http://www.researchandmarkets.com/research/6r...ay_markets
Luminex Remains Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 02, 11:10AM CST
We have reiterated our recommendation for Luminex at Neutral.
Global Flow Cytometry (Products, Application, Technology, and Users) Market Report 2012-2020
M2 - Thu Mar 06, 11:23AM CST
Research and Markets (http://www.researchandmarkets.com/research/hrg48g/flow_cytometry) has announced the addition of the "Flow Cytometry Market (Products, Application, Technology, and Users) - Current Trends, Opportunities, Industry Analysis, Size, Share and Global Forecast, 2012-2020" report to their offering. The flow cytometry market valued $3 billion in 2012 is further expected to reach $6.5 billion by 2020 growing at a CAGR of 30.9% Flow cytometry measures and analyzes cells of various characterizations through a light beam that is passed through a suspension of fluid. Several properties of the cell structure and functions can be studied with the help of this technique. The factor driving this market is the increase in scope of application areas such as drug discovery, stem cell sorting, marine biology, etc. The major limitation of this market is the cost of the instrument due to the need for high investment for production and maintenance. Flow cytometry finds its opportunities in the clinical and research approaches. KEY MARKET SEGMENTS BY PRODUCT - FC instruments - Reagents - Consumables - Software - Services - Accessories BY TECHNOLOGY - Cell based Technologies - Bead-based Technologies BY APPLICATION - Clinical - Apoptosis - Cell Cycle Analysis - Cell sorting - Cell Viability - Research Fields - Organ transplantation - Cancer - Immunodeficiency Disease - Hematology Haematological Malignancies BY END USERS - Commercial Organizations - Hospitals - Academic Institutes - Medical Schools - Clinical Testing Labs - Others KEY AUDIENCES: - Clinical institutes - Research institutes - Pharma and biotech companies - Academic institutes Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Flow Cytometry Market Overview Chapter 4 Flow Cytometry Market By Product Chapter 5 Flow Cytometry Market By Technology Chapter 6 Flow Cytometry Market By Application Chapter 7 Flow Cytometry Market By End User Chapter 8 Flow Cytometry Market By Geography Chapter 9 Company Profiles - Advanced Analytical Technologies Inc (AATI) - Amnis Corporation - Beckman Coulter - Becton - Dickinson & Co. - Ebioscience Inc. - Inc. - Life Technologies Corporation - Luminex Corporation - Merck Millipore - Morphosys AG - Partec GmbH For more information visit http://www.researchandmarkets.com/research/hr..._cytometry
NextGxDx Secures Series B Financing Round, Expands Board of Directors
PR Newswire - Wed Mar 05, 7:30AM CST
NextGxDx Inc., which provides an online genetic testing marketplace for healthcare professionals and hospitals, today announced the successful closing of the company's Series B round of financing, which was led by Voyent Partners and joined by the Nashville Capital Network. With the new investment, the company has expanded its board of directors to include new members Patrick J. Balthrop Sr., President and CEO of Luminex Corporation; Phil Hertik, former founder, chairman and CEO of Windsor Health Group; Jim Kever, principal at Voyent Partners; George Lazenby, former CEO of Emdeon; and G. Walter Loewenbaum II, chairman of Luminex Corp. and 3D Systems Corp.
12.6% Return Seen to Date on SmarTrend Luminex Call (LMNX)
Comtex SmarTrend(R) - Mon Mar 03, 11:05AM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 7 months, Luminex has returned 12.60% as of today's recent price of $18.35.
Global Gene Expression (DNA Microarray, Real-Time PCR, Next Generation Sequencing) Analysis Market 2014-2018
M2 - Thu Feb 27, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/dqf4hv/gene_expression) has announced the addition of the "Gene Expression Analysis Market by Technology, Consumables, Services & Applications - Global Forecast to 2018" report to their offering. The global market was valued at $2.6 billion in 2013 and is expected to reach $4.3 billion by 2018, at a CAGR of 10.4% Over the years, the gene expression analysis market, comprising of instruments, consumables, and services, has witnessed various technological advancements. These advancements have led to a growth in the number of gene expression applications. Some of the applications using gene expression analysis are pharmacogenomics, diagnostics, toxicogenomics, and biomarkers. However, the high cost of instruments and the need for skilled professionals to operate these highly sophisticated systems are factors that are hindering the market. The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. Scope of the Report - Market Penetration: Comprehensive information on the product portfolios and services offered by the top 10 players in the gene expression analysis market. The report analyzes instruments (by technology), consumables, and services - Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the gene expression analysis market - Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various gene expression analysis products across geographies - Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the gene expression analysis market - Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the gene expression analysis market Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 Gene Expression Analysis Market, By Segment 5 Gene Expression Analysis Instrumentation Market, By Technology 6 Gene Expression Analysis Consumables Market, By Product 7 Gene Expression Analysis Services Market, By Product 8 Gene Expression Analysis Market, By Application 9 Geographic Analysis 10 Competitive Landscape 11 Company Profiles - Affymetrix, Inc. - Agilent Technologies - Bio-Rad Laboratories, Inc. - Ge Healthcare (Subsidiary Of General Electric Company) - Illumina, Inc. - Life Technologies - Luminex Corporation - Oxford Gene Technology, Inc. - Perkinelmer, Inc. - Qiagen N.V. - Roche Diagnostics Corporation For more information visit http://www.researchandmarkets.com/research/dq...expression
Luminex Down 10.5% Since SmarTrend Downtrend Call (LMNX)
Comtex SmarTrend(R) - Fri Feb 21, 5:25PM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 7 months, Luminex has returned 10.45% as of today's recent price of $18.80.
High Throughput Screening - Forecast to 2018 Research Report
M2 - Tue Feb 11, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/mxsthj/high_throughput) has announced the addition of the "High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018" report to their offering. 'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018' In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 2013 to 2018. This technology offers the direct detection ability, which was not possible with cell-based assays. Moreover, this technology helps in the reduction of drug failure rate due to toxicity and is applicable for a majority of drug classes. In the HTS applications market, the target identification segment accounted for the largest share in 2013. The large share of this segment can be attributed to factors such as the availability of large compound libraries, presence of well-equipped HTS laboratories, and technological advancements. Large pharmaceutical and biotechnology companies are investing heavily in automation of HTS laboratories and are also entering into strategic partnerships and collaborations with research institutes, thereby leading to efficient utilization of HTS in varied application fields. Key Topics Covered: Introduction Executive Summary Premium Insights Market Overview High Throughput Screening Market, By Technology High Throughput Screening Market, By Product Global High Throughput Screening Market, By Application Global High Throughput Screening Market, By End Users Geographic Analysis Competitive Landscape Company Profiles List of Tables List of Figures Companies Mentioned - Agilent Technologies, Inc. - Aurora Biomed - Axxam Spa - Beckman Coulter, Inc. (A Subsidiary Of Danaher) - Bio-Rad Laboratories - Biofocus Dpi Ltd. - Intellicyt Corporation - Luminex Corporation - Perkinelmer, Inc. - Sigma Aldrich Corporation - Tecan Group Ltd. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/mx...throughput About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Luminex Earnings Beat but Fall Y/Y, Shares Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 05, 9:34AM CST
The decline in earnings can be attributable to lower revenues and higher costs during the quarter.
Luminex Corporation Reports Fourth Quarter And Full Year 2013 Results
PR Newswire - Mon Feb 03, 3:05PM CST
Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and year ended December 31, 2013. Financial and operating highlights include the following:
Microspheres Market by Type, Application & Raw Material - Global Trends & Forecasts to 2018
M2 - Thu Jan 30, 2:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/ph4dlg/microspheres) has announced the addition of the "Microspheres Market by Type, Application & Raw Material - Global Trends & Forecasts to 2018" report to their offering. Rising demand for efficiency and better materials with superior structural properties will drive the global microspheres market to $5.2 billion by 2018. The U.S. leads the world in terms of usage of advanced materials to increase the efficiency and reliability of operations which makes it the biggest market for microspheres. The market here is expected to experience the highest revenue growth during the next five years. The factors driving growth in the global microspheres market are: high demand from current & emerging applications, superior structural properties, recyclable & reusable, development & modernization of infrastructure, and increased demand for efficiency. The factors hindering the growth of this market are the fluctuating cost of raw materials, lack of quality control across developing countries, and huge investment in R&D. The market is growing slowly in Europe & Eurasia but it will continue to grow at significant rate in the Asia-Pacific region. Asia-Pacific is driven by countries such as China, the fastest growing country in global microspheres market. The microspheres market is still in infancy stage in Latin America. But this region is experiencing high growth on account of increased infrastructure spending. On the whole, it is evident that North America and Asia-Pacific are the most lucrative microspheres market. Most players in this industry are very small and manufacture highly customized products focusing on particular end user industry. U.S-based 3M is the largest player in terms of volume sales. Every company, big or small, wants to penetrate deeper into the existing market and at the same time expand into new and emerging markets to increase their sales margin; thereby increasing overall revenue. The companies involved in microspheres business adopted this strategy by expanding into emerging markets such as Asia-Pacific and South America. Most of the major companies manufacturing microspheres are headquartered in the U.S. and Europe. Medical technology will emerge as the most dominant application of the microspheres globally. Within raw material types, glass microspheres offer significant advantages over others and have wide applications in almost all industries such as cosmetics & personal care, paints & coatings, oil & gas and aerospace. Hence these are the market leaders in terms of size. Hollow microspheres being the most used microspheres in the market, captured most of the market. Scope of the report On the basis of geography: - North America - Europe & Eurasia - Asia-Pacific - Middle East & Africa - Latin America On the basis of applications: - Construction Composites - Medical Technology - Life Sciences & Biotechnology - Paints & Coatings - Cosmetics & Personal Care - Oil & Gas - Automotive - Aerospace - Other applications On the basis of types: - Hollow - Solid On the basis of raw materials: - Glass - Ceramic - Fly Ash - Polymer - Metallic - Others Key Topics Covered 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Manufacturing Process 6 Microspheres Market, By Types 7 Microspheres Market, By Applications 8 Microspheres Market, By Raw Materials 9 Microspheres Market, By Geography 10 Competitive Landscape 11 Company Profiles Companies Mentioned - 3M - Akzo Nobel Expancel - Cospheric - Dennert Poraver - Eko Export Sa - Henkel Ag & Co Kgaa - Induchem Holding - Luminex Corporation - MO Sci Corporation - Matsumoto Yushi-Seiyaku - Merit Medical Systems - Momentive Performance Materials - Osthoff Omega Group - Phosphorex Inc - Polysciences Incorporation - Potters Industries - Sigmund Lindner - Sinosteel Maanshan Institute Of Minning Research Company - Spherotech - Sunjin Chemical Co - Trelleborg Offshore & Construction For more information visit http://www.researchandmarkets.com/research/ph...crospheres About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Luminex Corporation To Present At 2014 Leerink Global Healthcare Conference
PR Newswire - Wed Jan 29, 3:05PM CST
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 2014 Leerink Global Healthcare Conference to be held February 12 -13, 2014, in New York, NY.
Downtrend Call Working As Luminex Stock Falls 12.9% (LMNX)
Comtex SmarTrend(R) - Tue Jan 28, 9:32AM CST
SmarTrend identified a Downtrend for Luminex (NASDAQ:LMNX) on July 30th, 2013 at $21.00. In approximately 6 months, Luminex has returned 12.93% as of today's recent price of $18.28.
2013 Report on the International Flow Cytometry Market - Forecasts to 2016
M2 - Mon Jan 27, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/ddp8kh/global_flow) has announced the addition of the "2013 Report on the International Flow Cytometry Market - Forecasts to 2016" report to their offering. A large number of companies are operating in the Global Flow Cytometry market. In recent years, the Global Flow Cytometry market has been witnessing significant consolidation as a result of many mergers and acquisitions. This trend is expected to continue during the forecast period as vendors attempt to strengthen or retain their market position. The market consolidation has resulted in stronger competitors that are better able to compete as sole-source vendors to end-users. For instance, in March 2011, Becton, Dickinson and Company completed the acquisition of Accuri Cytometers Inc., and in August 2011, EMD Millipore acquired Amnis Corp. One of the key drivers is the increase in technological advancements. The latest technological advancements and sophisticated approaches in various healthcare operations have increased the demand for flow cytometry. The technological innovations employed in the drug discovery and development process require flow cytometry on a large scale. The introduction of compact affordable flow cytometry equipment and user-friendly software has helped in moving flow cytometry from core laboratories to small research facilities. The introduction of multicolor flow cytometers with multiple lasers that are capable of simultaneously detecting up to 18 cell parameters is also having a strong impact on the growth of the market. Further, the report reveals that one of the key challenges is the intense competition among the flow cytometer vendors. Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Coverage 4. Market Landscape 5. Geographical Segmentation 6. Vendor Landscape 7. Buying Criteria 8. Market Growth Drivers 9. Drivers and their Impact 10. Market Challenges 11. Impact of Drivers and Challenges 12. Market Trends 13. Key Vendor Analysis 14. Other Reports in this Series Companies Mentioned: - Becton - Dickinson and Company - Danaher Corp. - EMD Millipore Corp. - Cytek Development Inc. - Cytopeia Inc. - Partec GmbH - TTP LabTech Ltd. - eBioscience Inc. - Luminex Corp. - Sony Biotechnology Inc. For more information visit http://www.researchandmarkets.com/research/dd...lobal_flow
Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014
PR Newswire - Tue Jan 14, 3:05PM CST
Luminex Corporation (Nasdaq: LMNX) today announced that it expects to report results for the fourth quarter of 2013 on Monday, February 3, 2014. A press release announcing the results is scheduled for release after the close of trading.
North America to Lead Flow Cytometry Market Till 2020, States Allied Market Research in Its Report Published at MarketPublishers.com
PRWeb - Wed Jan 08, 9:52AM CST
The flow cytometry market is currently on an upward trend, driven by ongoing technological advancements alongside the advantages the flow cytometry technology has, such as easy-to-handle instruments, auto-calibration, and broader accessibility. The key restraints to the market growth include, among others, the lack of awareness amid prospective users, the increasing need for trained personnel, and high size and cost of instruments. Hospitals, commercial organisations, clinical testing laboratories, medical schools and academic institutes are the main end-users of the technology. The entrenched players of the worldwide flow cytometry market include, amid others, Morphosys AG, Partech GmbH, Beckman Coulter, Life technologies, Amnis, eBioscience Inc, Luminex Corporation, and Becton Dickinson & Co.
Downgrade Alert for Luminex (LMNX)
Comtex SmarTrend(R) - Wed Jan 08, 7:03AM CST
Luminex (NASDAQ:LMNX) was downgraded from Neutral to Underweight at JP Morgan today. The stock closed yesterday at $18.48 on volume of 331,000 shares, above average daily volume of 141,000. There is potential upside of 5.5% for shares of Luminex based on a current price of $18.48 and an average consensus analyst price target of $19.50. Luminex shares should first meet resistance at the 50-day moving average (MA) of $18.86 and find additional resistance at the 200-day MA of $19.37.
Luminex Corporation To Present At JP Morgan Healthcare Conference
PR Newswire - Thu Jan 02, 3:05PM CST
Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the 32nd Annual JP Morgan Healthcare Conference to be held January 13-16, 2014, in San Francisco, CA.
Global Microarray Market Report 2013
M2 - Tue Dec 17, 4:25AM CST
Research and Markets (http://www.researchandmarkets.com/research/6rcmmv/microarray_markets) has announced the addition of the "Global Microarray Market Report 2013" report to their offering. "Global Microarray Market Report 2013", focuses on microarray technologies multiplex and miniaturize the analysis of tens of thousands of molecules for a variety of assays, including drug binding, molecular interactions, enzyme activity and pathway identification. These microarrays, which include DNA microarrays, protein microarrays, tissue microarrays, low complexity microarrays and carbohydrate microarrays, are excellent tools for gene expression profiling, biomarker profiling and diagnostics. Pharmaceutical and biotechnology researchers use microarrays to streamline drug target identification, selection, validation and predictive testing. This report also examines companies that are actively developing and marketing microarray instrumentation or microarray biochips. Detailed tables and charts with sales forecasts and marketshare data are also included. Key Topics Covered: 1. Overview 2. The Commercial Opportunity for Microarrays 3. Microarray Overview 4. DNA Microarrays 5. Protein Microarrays 6. Current DNA Microarrays 7. Current Protein Microarrays 8. Technology 9. Lab-on-a-Chip Technologies 10. Applications 10.1 DNA Microarrays in Gene Expression 10.2 DNA Microarrays in SNP Analysis 10.3 DNA Microarrays in Cancer 10.4 Protein Microarrays 10.5 Target/Biomarker Discovery 10.6 Drug Discovery and Development (Gene and Protein Microarrays) 10.7 Clinical Diagnostics (Gene and Protein Microarrays) 10.8 RNA Microarrays 10.9 Oligo Microarrays 10.10 Yeast Microarrays 10.11 Antibody Arrays 10.12 Arrays for Toxicogenomics 10.13 Microbial Applications 10.14 The Market for Microbial Genotyping Products 11. Competitive Landscape 11.1 The Commercial Microarray Market 11.2 Sector Consolidation 11.3 Regulatory Matters 11.4 Legal Matters 11.5 Intellectual Property 11.6 Mergers, Acquisitions and Agreements 12. Company Profiles Companies Mentioned: - AyoxxA - bioM rieux SA - CombiMatrix Corporation - Discerna - Exiqon - Fluidigm Corporation - Gyros AB - Healthcare IT, Inc - Isu Abxis Co, Ltd - Luminex Corporation - Myriad Genetics, Inc - NextGen Sciences PLC - One Lambda - ProteoGenix - QIAGEN - Roche NimbleGen, Inc - SuperBioChips Laboratories - Theranostic Health, Inc - US Biomax - Veredus Laboratories Pte Ltd - Zeptosens For more information visit http://www.researchandmarkets.com/research/6r...ay_markets
Luminex Remains Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 02, 11:10AM CST
We have reiterated our recommendation for Luminex at Neutral.
